SMITHKLINE BEECHAM Rx SALES UP 5% IN FIRST QUARTER; OTHER DRUG MAJORS ALSO REPORT SLOWER SALES THAN EARNINGS GROWTH; MMD BUCKS TREND WITH 21% SALES GAIN

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".